87
DAFTAR PUSTAKA
1. Corrigan JJ, Boineau GF. Hemolytic-Uremic Syndrome. Pediatrics.
2001;22:365–9.
2. Picard C, Burtey S, Bornet C, Curti C, Montana M, Vanelle P.
Pathophysiology and treatment of typical and atypical hemolytic uremic
syndrome typique et atypique. Pathol Biol [Internet]. 2015;63:136–43.
Available from: http://dx.doi.org/10.1016/j.patbio.2015.03.001
3. Trompeter, R.S., Schwartz, R., Chantler, C., Dillon, M.J., Haycock, G.b.,
Kay, R., Barrat TM. Haemolytic-uraemic syndrome : an analysis of
prognostic features. Arch Dis Child Dis Child. 1983;58:101–5.
4. Noris M, Remuzzi G. Atypical hemolytic–uremic syndrome. N Eng J Med.
2009;361:1676–87.
5. Dobilien, D., Mitkien, R., Medzevi, Ai., Dar, E., Jankauskien A. Long-term
follow-up of children with typical hemolytic uremic syndrome. Medicina
(B Aires). 2015;1:146–51.
6. Loirat C, Frémeaux-bacchi V. Atypical hemolytic uremic syndrome.
Orphanet J Rare Dis. 2011;6:1–30.
7. Gipson DS, Massengill SF, Yao L, Nagaraj S, William E, Mahan JD, et al.
Management of childhood onset nephrotic syndrome. Pediatrics.
2009;124:747–58.
8. Trihono P, Alatas H, T T, SO P, MS N, Soemyarso NA. Kompendium
Nefrologi Anak. In: KOMPENDIUM NEFROLOGI. 2012. p. 72–80.
9. Caletti MG, Gallo G, Gianantonio CA. Development of focal segmental
sclerosis and hyalinosis in hemolytic uremic syndrome. Pediatr Nephrol.
1996;10:687–92.
10. Geary DF. Hemolytic Uremic Syndrome. J Pediatr. 2007;151:113–4.
11. Polito MG, Kirsztajn GM. Thrombotic microangiopathies: thrombotic
thrombocytopenic purpura / hemolytic uremic syndrome. J Bras Nefrol
ʹ orgão Of Soc Bras e Latino-Americana Nefrol. 2010;32:303–15.
12. Fakhouri F, Frémeaux-bacchi V, Loirat C. Atypical hemolytic uremic
syndrome : From the rediscovery of complement to targeted therapy. Eur
J Intern Med [Internet]. 2013;24:492–5. Available from:
http://dx.doi.org/10.1016/j.ejim.2013.05.008
13. Kavanagh D, Goodship THJ, Richards A. Atypical haemolytic uraemic
syndrome. 2006;5–22.
GAGAL GINJAL KRONIK, SINDROM NEFROTIK DAN HIPERTENSI PADA SINDROM HEMOLITIKUREMIKDESSY SHINTA MURTYUniversitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
88
14. Stergiou N, Kapogiannis A, Orfanou I, Grapsa B, Roma E. Atypical
hemolytic-uremic syndrome ( HUS ) with recovery after a long-lasting
anuria : a case report. Hippokratia. 2011;15:90–2.
15. Siegler, R.L., Milligan MK, Burningham, T.H., Christofferson, R.D.,
Shien-young, C., Jorde LB. Long-term outcome and prognostic indicators
in the hemolytic uremic syndrome. J Pediatr. 1991;2:195–200.
16. Krishnan RG. Nephrotic syndrome. Paediatr Child Health (Oxford)
[Internet]. 2012;22:337–40. Available from:
http://dx.doi.org/10.1016/j.paed.2012.02.004
17. Beattie J. Guideline for the Management of Nephrotic Syndrome. 2007. 1-8
p.
18. Braga A. Revised guidelines for management of steroid-sensitive nephrotic
syndrome. Indian J Nephrol. 2008;18:31–9.
19. Czarniak P, Zurowska A. Treatment strategies to prevent renal damage in
hypertensive children. Curr Hypertens Rep. 2014;16:423.
20. Shults J, Ph D, Zemel BS, Ph D, Foster BJ, Stallings VA. Long-Term,
High-Dose Glucocorticoids and Bone Mineral Content in Childhood
Glucocorticoid-Sensitive Nephrotic Syndrome. 2004;868–75.
21. Roccella, E.J., Hoke, T., Hunt, C.E., Pearson G. Fourth Report On
Diagnosis , Evaluation, and Treatment of High Blood Pressure in Children
and Adolescents. 2005.
22. Ekoyan G, Lameire N, Eckardt K-U, Kasiske BL, Wheeler DC. KDIGO
clinical practice guideline for the management of blood pressure in chronic
kidney disease. Kidney Int. 2012;2:Supplements.
23. Venkataraman R, Kellum JA. Defining Acute Renal Failure : The RIFLE
Criteria. J Intensive Care Med. 2007;22:187–93.
24. NHS Commisioning Board. Patent foramen ovale (PFO) closure. 2013. 1-
23 p.
25. Park MK, Salamat M. Park’s the pediatric cardiology handbook : fifth
edition. 2016. 237 p.
26. Whyte DA, Fine RN. Chronic kidney disease in children. Pediatr Rev.
2008;29:335–41.
27. Warady BA, Donna S, Foster B, Goldstein SL, Frederick K, Sarah E L, et
al. KDOQI clinical practice guideline for nutrition in children with chronic
kidney disease. Am J Kidney Dis. 2009;53:Suppl 2.
28. Ekoyan G, Lameire N, Eckardt K-U, Kasiske BL, Wheeler DC. KDIGO
GAGAL GINJAL KRONIK, SINDROM NEFROTIK DAN HIPERTENSI PADA SINDROM HEMOLITIKUREMIKDESSY SHINTA MURTYUniversitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
89
2012 clinical practice guideline for the evaluation and management of
chronic kidney disease. Kidney Int. 2013;3:Supplements.
29. Cobeñas CJ, Alconcher LF, Spizzirri AP, Rahman RC. Long-term follow-
up of Argentinean patients with hemolytic uremic syndrome who had not
undergone dialysis. Pediatr Nephrol. 2007;22:1343–7.
30. Davis PB. Hemolytic Uremic Syndrome and. 2007;113–4.
31. Noris M, Remuzzi G. Glomerular diseases dependent on complement
activation. Am J Kidney Dis [Internet]. 2015;66:359–75. Available from:
http://dx.doi.org/10.1053/j.ajkd.2015.03.040
32. Hernández R. How to treat corticosteroid-resistant idiopathic focal
segmental glomerulosclerosis ? Nefrologia. 2011;31:247–50.
33. Greenbaum LA. Atypical Hemolytic Uremic Syndrome. Adv Pediatr
[Internet]. 2015;61:335–56. Available from:
http://dx.doi.org/10.1016/j.yapd.2014.04.001
34. Taylor, C. M., Machin, S., Wigmore S. Clinical Practice Guideline for the
Management of Atypical Haemolytic Uraemic Syndrome in the United
Kingdom. :1–22.
35. Yap H-K, Liu ID, Tay W-C. Pediatric nephrology on the go. 2012. 167-185
p.
36. Mahan JD, Warady BA. Assessment and treatment of short stature in
pediatric patients with chronic kidney disease : a consensus statement.
Pediatr Nephrol. 2006;21:917–30.
37. Bakr A, Amr M, Sarhan A, Hammad A, Ragab M. Psychiatric disorders in
children with chronic renal failure. Pediatr Nephrol. 2007;22:128–31.
38. Mckenna AM, Keating LE, Vigneux A, Stevens S, Williams A, Geary DF.
Quality of life in children with chronic kidney disease — patient and
caregiver assessments. Nephro Dial Transpl. 2006;21:1899–905.
39. Sealy L, Inward C, Burren C, Smith Trace. Growth Monitoring Guidelines
for Children with Chronic Kidney Disease. Bristol Royal Hospital for
Children. 2011. p. 1–7.
40. Stanbury RM, Graham EM. Systemic corticosteroid therapy — side efects
and their management. 1998;704–8.
41. Murphy M. The PSC-17 : a brief Pediatric Symptom Checklist with
psychosocial problem subscales. Ambul Child Heal. 1999;5:225–36.
42. Departemen Kesehatan RI. Pedoman Teknis Penilaian Rumah Sehat. Vol.
1. 2002. 22 p.
GAGAL GINJAL KRONIK, SINDROM NEFROTIK DAN HIPERTENSI PADA SINDROM HEMOLITIKUREMIKDESSY SHINTA MURTYUniversitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
90
43. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height ,
weight , height velocity , weight velocity , and stages of puberty. Arch Dis
Child. 1976;51:170–9.
44. Salas P, Pinto V, Rodriguez J, Zambrano MJ, Mericq V. Growth
retardation in children with kidney disease. Int J Endocrinol. 2013;13:1–9.
45. Seikaly MG, Salhab N, Gipson D. Stature in children with chronic kidney
disease : analysis of NAPRTCS database. Pediatr Nephrol. 2006;21:793–
9.
46. Furth SL, Hwang W, Yang C, Neu AM, Fivush BA, Powe NR. Growth
failure , risk of hospitalization and death for children with end-stage renal
disease. Pediatr Nephrol. 2002;17:450–5.
47. Modini VM, Seikaly MG. Growth in Children After Renal Transplantation:
An Update. Dial Transplant. 2010;39:516–21.
48. Mekahli D, Shaw V, Ledermann SE, Rees L. Longterm outcome of infants
with severe chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:1–8.
49. Foster BJ, Leonard MB. Measuring nutritional status in children with
chronic kidney disease 1 – 3. Am J Clin Nutr. 2004;80:801–14.
50. Rees L, Mak RH. Nutrition and growth in children with chronic kidney
disease. Nat Publ Gr [Internet]. 2011;7:615–23. Available from:
http://dx.doi.org/10.1038/nrneph.2011.137
51. Rahajoe NN, Basir D, Makmuri MS, Kartasasmita CB. Pedoman Nasional
Tuberkulosis Anak. 2007. 47-66 p.
52. Vaziri ND. Disorders of lipid metabolism in nephrotic syndrome:
mechanisms and consequences. Kidney Int [Internet]. 2016;1–12. Available
from: http://dx.doi.org/10.1016/j.kint.2016.02.026
53. Willis K, Cheung M, Slifer S. KDIGO clinical practice guideline for lipid
management in chronic kidney disease. Kidney Int. 2013;3.
54. Vivante A, Calderon-margalit R, Skorecki K. Hematuria and risk for end-
stage kidney disease. Curr Opin Nephrol Hypertens. 2013;22:325–30.
55. Lin HY, Yen C, Lim L, Hwang D, Tsai J, Hwang S, et al. Microscopic
Haematuria and Clinical Outcomes in Patients With Stage 3 – 5
Nondiabetic Chronic Kidney Disease. Nat Publ Gr [Internet]. 2015;5:1–10.
Available from: http://dx.doi.org/10.1038/srep15242
56. Staples AO, Wong CS, Smith JM, Gipson DS, Filler G, Warady BA, et al.
Anemia and Risk of Hospitalization in Pediatric Chronic Kidney Disease.
Clin J Am Soc Nephrol. 2009;4:48–56.
GAGAL GINJAL KRONIK, SINDROM NEFROTIK DAN HIPERTENSI PADA SINDROM HEMOLITIKUREMIKDESSY SHINTA MURTYUniversitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
91
57. Willis K, Cheung M, Slifer S. KDIGO clinical practice guideline for
anemia in chronic kidney disease. Kidney Int. 2012;2.
58. Bacchetta J, Harambat J, Cochat P, Salusky IB, Wesseling-perry K. The
consequences of chronic kidney disease on bone metabolism and growth in
children. Nephrol Dial Transpl. 2012;27:3063–71.
59. Shaman AM, Kowalski SR. Hyperphosphatemia Management in Patients
with Chronic Kidney Disease. Saudi Pharm J [Internet]. 2016;24:494–505.
Available from: http://dx.doi.org/10.1016/j.jsps.2015.01.009
60. Martin KJ, Gonza EA. Prevention and control of phosphate retention
/hyperphosphatemia in CKD-MBD. Clin J Am Soc Nephrol. 2011;6:440–6.
61. Wesseling-perry K, Salusky IB. Chronic Kidney Disease : Mineral and
Bone Disorder in Children. Semin Nephrol. 2014;33:169–79.
62. Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney
disease in children. Clin Kidney J. 2016;9:583–91.
63. Ketteler M, Wüthrich RP, Floege J. Management of hyperphosphataemia in
chronic kidney disease — challenges and solutions. Clin Kidney J.
2013;23:128–36.
64. Ekoyan G, Eckardt K-U, Kasiske BL, Moe SM, Drucke TB, Block GA.
KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation,
Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone
Disorder ( CKD-MBD ). Kidney Int. 2009;76:121–30.
65. Lau WL, Kalantar-Zadeh K, Kovesdy CP MR. Alkaline phosphatase :
Better than PTH as a marker of cardiovascular and bone disease ?
Hemodial Int. 2014;18:720–4.
66. Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, Mcallister CJ, et
al. Serum Alkaline Phosphatase Predicts Mortality among Maintenance
Hemodialysis Patients. J Am Soc Nephrol. 2008;19:2193–203.
67. Shankar O, Sah P, Qing YX. Associations between hyperuricemia and
chronic kidney disease : a review. Nephro Urol Mon. 2015;7:e272333.
68. Johnson RJ, Nakagawa T, Jalal D, Sánchez-lozada LG, Kang D, Ritz E.
Uric acid and chronic kidney disease : which is chasing which ? Nephrol
Dial Transpl. 2013;28:2221–8.
69. Goicoechea M, Vinuesa SG De, Verdalles U, Ruiz-caro C, Ampuero J,
Rinco A, et al. Effect of allopurinol in chronic kidney disease progression
and cardiovascular risk. Clin J Am Soc Nephrol. 2010;5:1388–93.
70. Shah SN, Abramowitz MK, Hostetter TH, Melamed ML. Serum bicarbonat
levels and progression of kidney disease : cohort study. Am J Kidney Dis.
GAGAL GINJAL KRONIK, SINDROM NEFROTIK DAN HIPERTENSI PADA SINDROM HEMOLITIKUREMIKDESSY SHINTA MURTYUniversitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
92
2015;54:270–7.
71. Kraut JA, Madias NE. Metabolic Acidosis of CKD : An Update. Am J
Kidney Dis [Internet]. 2016;67:307–17. Available from:
http://dx.doi.org/10.1053/j.ajkd.2015.08.028
72. Menon V, Tighiouart H, Vaughn NS. Serum bicarbonate and long-term
outcomes in CKD. Am J Kidney Dis [Internet]. 2010;56:907–14. Available
from: http://dx.doi.org/10.1053/j.ajkd.2010.03.023
73. Kovesdy CP, Anderson JE, Kalantar-zadeh K. Association of serum
bicarbonate levels with mortality in patients with non-dialysis-dependent
CKD. Nephrol Dial Transpl. 2008;24:265–8.
74. Chen W, Abramowitz MK. Metabolic acidosis and the progression of
chronic kidney disease. BMC Nephrol. 2014;15:1–8.
75. Aldigier JC, Kanjanbuch T, Ma L, Brown NJ, Fogo AB. Regression of
existing glomerulosclerosis by inhibition of aldosterone. J Am Soc
Nephrol. 2005;16:3306–14.
76. Yaqoob MM. Treatment of Acidosis in CKD. Clin J Am Soc Nephrol.
2013;8:342–3.
77. Scialla JJ, Anderson CAM. Dietary acid load: a novel nutritional target in
chronic kidney disease. Adv Chronic Kidney. 2014;20:141–9.
78. Adeva-andany MM, Fernández-fernández C, Mouriño-bayolo D, Castro-
quintela E, Domínguez-montero A. Sodium Bicarbonate Therapy in
Patients with Metabolic Acidosis. Sci World J. 2014;2014:1–14.
79. Mathews T, Minifio AM, Osterman MJ, Strobino DM, Guyer B. Annual
Summary of Vital Statistics : 2008. Pediatrics. 2008;127:146–57.
80. Collins AJ, Foley RN, Chavers B, Gilbertson D. US Renal Data System
2011 Annual Data Report. Am J Kidney Dis. 2012;59:supplement.
81. Kumar P, O’Connor NR. Conservative Management of End-Stage Renal
Disease without Dialysis : A Systematic Review. J Palliat Med.
2012;15:228–35.
82. Mitsnefes MM. Cardiovascular complications of pediatric chronic kidney
disease. 2008;27–39.
83. Jaap W Groothoff, Gruppen MP, Offringa M, Hutten J, Lilien MR, Kar NJ
Van de, et al. Mortality and causes of death of end-stage renal disease in
children : A Dutch cohort study. Kidney Int. 2002;61:621–9.
84. Mcdonald SP, Craig JC. Long-Term Survival of Children with End-Stage
Renal Disease. N Eng J Med. 2004;350:2654–62.
GAGAL GINJAL KRONIK, SINDROM NEFROTIK DAN HIPERTENSI PADA SINDROM HEMOLITIKUREMIKDESSY SHINTA MURTYUniversitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
93
85. Scavarda VT, Andrade M De, Carvalho AC, Moises VA. Children with
chronic renal disease undergoing dialysis or conservative treatment –
differences in structural and functional echocardiographic parameters.
Echocardiography. 2014;23:1131–7.
GAGAL GINJAL KRONIK, SINDROM NEFROTIK DAN HIPERTENSI PADA SINDROM HEMOLITIKUREMIKDESSY SHINTA MURTYUniversitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/